Zhejiang Shengda Bio-Pharm Co., Ltd.SSE: 603079

Report for Q1 2025

Apr 28, 2025 · Issued by Zhejiang Shengda Bio-Pharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 28, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-319

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix

Earlier from Zhejiang Shengda Bio-Pharm

Announcement on the Resolution of the 1st Extraordinary General Meeting in 2025Apr 24, 2025

Later from Zhejiang Shengda Bio-Pharm

Announcement on Convening the 2024 Annual and Q1 2025 Performance BriefingMay 20, 2025
Announcement on Resolution of the 17th Meeting of the 4th Board of DirectorsMay 23, 2025
Announcement on Resolutions of the 2024 Annual General MeetingMay 27, 2025
Announcement on Opening Special Account for Raised Funds and Signing Agreement on Supervision over Deposit in Special Account for Raised FundsJun 17, 2025
Announcement on Results of Issuing Shares to Specific Objects and Changes in Share CapitalJun 28, 2025

All Zhejiang Shengda Bio-Pharm news releases

Follow Zhejiang Shengda Bio-Pharm into a list and get an email when it puts out news.

Follow Zhejiang Shengda Bio-Pharm